The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Spirit Digital’s CliniTouch Vie platform uses remote monitoring to help patients self-manage conditions and enable healthcare teams to proactively monitor patients safely at their home or usual place of residence, enabling prioritised focus on those who need support. The platform supports pathways and conditions including Chronic Obstructive Pulmonary Disease (COPD), heart failure services, frailty patients and care home healthcare, and early discharge and post surgery services. The platform has been particularly relevant during the Covid-19 pandemic as COPD patients are in the high risk category.
Nu Vision eye treatments offer an alternative to eye surgery by using preserved amniotic membrane (membrane from placentas) to treat damaged corneas and promote healing. The products are unique, as the material is preserved making it easy to store and accessible to hospitals. The company is in the process of expanding into using their product to facilitate the treatment of chronic wounds, such as diabetic foot ulcers.
Following innovation exchange work focussing on mental health, EMAHSN supported QbTest a diagnostic tool which measures the core indicator symptoms of Attention Deficit Hyperactivity Disorder (ADHD). On average, QbTest can reduce time to diagnosis by 153 days and provide 20% cost reductions.
ChatHealth is a secure messaging service which allows service users to have conversations with health professionals via text, providing quick and confidential advice. Following EMAHSN support, ChatHealth is now available to nearly 2 million young people across the UK.
